| chemoattractant activity | GO:0042056 | 6.48 |
| drug binding | GO:0008144 | 5.03 |
| GO:0050786 | 7.34 |
| nucleic acid binding transcription factor activity | GO:0001071 | 2.65 |
| nucleic acid binding | GO:0003676 | 1.44 |
| DNA binding | GO:0003677 | 1.92 |
| heterocyclic compound binding | GO:1901363 | 1.06 |
| sequence-specific DNA binding | GO:0043565 | 2.79 |
| structure-specific DNA binding | GO:0043566 | 4.98 |
| sequence-specific double-stranded DNA binding | GO:1990837 | 3.2 |
| enhancer binding | GO:0035326 | 5.21 |
| transcription factor binding | GO:0008134 | 3.46 |
| GO:0097100 | 8.35 |
| double-stranded DNA binding | GO:0003690 | 3.09 |
| single-stranded DNA binding | GO:0003697 | 5.17 |
| regulatory region nucleic acid binding | GO:0001067 | 3.03 |
| poly(A) RNA binding | GO:0044822 | 2.69 |
| DNA secondary structure binding | GO:0000217 | 6.6 |
| DNA binding, bending | GO:0008301 | 6.74 |
| protein domain specific binding | GO:0019904 | 3.32 |
| enhancer sequence-specific DNA binding | GO:0001158 | 5.36 |
| transcription regulatory region DNA binding | GO:0044212 | 3.03 |
| four-way junction DNA binding | GO:0000400 | 7.03 |
| GO:0044378 | 9.74 |
| transcription factor activity, sequence-specific DNA binding | GO:0003700 | 2.65 |
| organic cyclic compound binding | GO:0097159 | 1.05 |
| transcription regulatory region sequence-specific DNA binding | GO:0000976 | 3.24 |
| RNA binding | GO:0003723 | 2.36 |
| protein binding | GO:0005515 | 0.46 |
| regulatory region DNA binding | GO:0000975 | 3.03 |
| receptor binding | GO:0005102 | 2.43 |
| damaged DNA binding | GO:0003684 | 5.58 |
| binding | GO:0005488 | 0.18 |